ASX - By Stock
|
AFL |
Re:
Ann: AFL Entitlement Offer Results
|
|
vagabond84
|
5 |
738 |
3 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
5
|
738
|
3
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Change of Director's Interest Notice (DP)
|
|
vagabond84
|
21 |
4.7K |
1 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
21
|
4.7K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
vagabond84
|
164 |
42K |
1 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
164
|
42K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
vagabond84
|
164 |
42K |
4 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
42K
|
4
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
vagabond84
|
164 |
42K |
10 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
42K
|
10
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
vagabond84
|
164 |
42K |
1 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
42K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
vagabond84
|
164 |
42K |
10 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
42K
|
10
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
vagabond84
|
164 |
42K |
3 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
42K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
vagabond84
|
164 |
42K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
42K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
vagabond84
|
164 |
42K |
3 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
164
|
42K
|
3
|
|
ASX - By Stock
|
NTD |
Re:
Ann: Appendix 4D and Half-Year Financial Report
|
|
vagabond84
|
24 |
9.9K |
4 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
24
|
9.9K
|
4
|
|
ASX - By Stock
|
WOW |
Re:
Four Corners - Supermarket Power
|
|
vagabond84
|
59 |
14K |
8 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
59
|
14K
|
8
|
|
ASX - By Stock
|
WOW |
Re:
Four Corners - Supermarket Power
|
|
vagabond84
|
59 |
14K |
2 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
59
|
14K
|
2
|
|
ASX - By Stock
|
MAH |
Is real depreciation expense more than reported?
|
|
vagabond84
|
3 |
953 |
1 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
3
|
953
|
1
|
|
ASX - By Stock
|
WOW |
Re:
Four Corners - Supermarket Power
|
|
vagabond84
|
59 |
14K |
1 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
59
|
14K
|
1
|
|
ASX - By Stock
|
SWM |
Re:
Why SWM is worth more than $1.50 per share
|
|
vagabond84
|
202 |
53K |
2 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
202
|
53K
|
2
|
|
ASX - By Stock
|
SWF |
Re:
Ann: Notification of cessation of securities - SWF
|
|
vagabond84
|
44 |
13K |
1 |
24/02/24 |
24/02/24 |
ASX - By Stock
|
44
|
13K
|
1
|
|
ASX - By Stock
|
WOW |
Re:
Four Corners - Supermarket Power
|
|
vagabond84
|
59 |
14K |
8 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
59
|
14K
|
8
|
|
ASX - By Stock
|
WOW |
Re:
Four Corners - Supermarket Power
|
|
vagabond84
|
59 |
14K |
13 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
59
|
14K
|
13
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Efficacy Data for ATH434 in a Primate Model of PD
|
|
vagabond84
|
32 |
10K |
0 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
32
|
10K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Efficacy Data for ATH434 in a Primate Model of PD
|
|
vagabond84
|
32 |
10K |
0 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
32
|
10K
|
0
|
|
ASX - By Stock
|
FOR |
Re:
Ann: Ceasing to be a substantial holder for WSP
|
|
vagabond84
|
3 |
987 |
2 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
3
|
987
|
2
|
|
ASX - By Stock
|
PBH Betting |
Re:
credit card ban gambling australia
|
|
vagabond84
|
9 |
5.3K |
1 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
9
|
5.3K
|
1
|
|
ASX - By Stock
|
HVN |
Re:
Ann: Dividend/Distribution - HVN
|
|
vagabond84
|
32 |
12K |
12 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
32
|
12K
|
12
|
|
ASX - By Stock
|
EZZ |
Re:
Ann: Preliminary Final Report
|
|
vagabond84
|
34 |
7.9K |
2 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
34
|
7.9K
|
2
|
|
ASX - By Stock
|
EZZ |
Re:
Ann: Preliminary Final Report
|
|
vagabond84
|
34 |
7.9K |
0 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
34
|
7.9K
|
0
|
|
ASX - By Stock
|
EZZ |
Re:
Ann: Preliminary Final Report
|
|
vagabond84
|
34 |
7.9K |
1 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
34
|
7.9K
|
1
|
|
ASX - By Stock
|
EZZ |
Re:
Ann: Preliminary Final Report
|
|
vagabond84
|
34 |
7.9K |
3 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
34
|
7.9K
|
3
|
|
ASX - By Stock
|
HVN |
Re:
buying opportunity coming
|
|
vagabond84
|
345 |
202K |
12 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
345
|
202K
|
12
|
|
ASX - By Stock
|
MTB |
Re:
Ann: Oversubscribed Placement
|
|
vagabond84
|
14 |
3.5K |
2 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
14
|
3.5K
|
2
|
|
ASX - By Stock
|
HVY |
Re:
Ann: Pre-Paid Royalty Mandate
|
|
vagabond84
|
40 |
13K |
2 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
40
|
13K
|
2
|
|
ASX - By Stock
|
HVY |
Re:
Ann: Pre-Paid Royalty Mandate
|
|
vagabond84
|
40 |
13K |
2 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
40
|
13K
|
2
|
|
ASX - By Stock
|
HVY |
Re:
Ann: Ceasing to be a substantial holder
|
|
vagabond84
|
7 |
3.0K |
4 |
16/07/23 |
16/07/23 |
ASX - By Stock
|
7
|
3.0K
|
4
|
|
ASX - By Stock
|
MTB |
Re:
Forrester the Challenger
|
|
vagabond84
|
6 |
1.2K |
4 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
6
|
1.2K
|
4
|
|
ASX - By Stock
|
HVY |
Re:
Ann: Updated Port Gregory JORC Mineral Resource Increased by 23%
|
|
vagabond84
|
72 |
25K |
3 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
72
|
25K
|
3
|
|
ASX - By Stock
|
MTB |
Re:
Ann: Significant Gallium Exploration Target at Kihabe Deposit
|
|
vagabond84
|
48 |
11K |
0 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
48
|
11K
|
0
|
|
ASX - By Stock
|
NEC |
short candidate
|
|
vagabond84
|
11 |
4.6K |
1 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
11
|
4.6K
|
1
|
|
ASX - By Stock
|
MTB |
Re:
Ann: Significant Gallium Exploration Target at Kihabe Deposit
|
|
vagabond84
|
48 |
11K |
0 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
48
|
11K
|
0
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives US FDA Clearance for FebriDx
|
|
vagabond84
|
420 |
126K |
1 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
420
|
126K
|
1
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives US FDA Clearance for FebriDx
|
|
vagabond84
|
420 |
126K |
3 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
420
|
126K
|
3
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives US FDA Clearance for FebriDx
|
|
vagabond84
|
420 |
126K |
2 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
420
|
126K
|
2
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives US FDA Clearance for FebriDx
|
|
vagabond84
|
420 |
126K |
1 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
420
|
126K
|
1
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives US FDA Clearance for FebriDx
|
|
vagabond84
|
420 |
126K |
2 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
420
|
126K
|
2
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives US FDA Clearance for FebriDx
|
|
vagabond84
|
420 |
126K |
1 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
420
|
126K
|
1
|
|
ASX - By Stock
|
LDX |
Re:
Ann: Lumos Receives US FDA Clearance for FebriDx
|
|
vagabond84
|
420 |
126K |
1 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
420
|
126K
|
1
|
|
ASX - By Stock
|
MAH |
Re:
Ann: Pause in Trading
|
|
vagabond84
|
4 |
1.4K |
5 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
4
|
1.4K
|
5
|
|
ASX - By Stock
|
AFL |
Re:
Ann: AFL delivers improved performance & a profitable Q3 FY23
|
|
vagabond84
|
10 |
4.0K |
3 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
10
|
4.0K
|
3
|
|
ASX - By Stock
|
EZZ |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vagabond84
|
22 |
6.6K |
3 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
22
|
6.6K
|
3
|
|
ASX - By Stock
|
CXZ |
Re:
Ann: Quarterly Report
|
|
vagabond84
|
41 |
16K |
1 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
41
|
16K
|
1
|
|
ASX - By Stock
|
CXZ |
Re:
Ann: Quarterly Report
|
|
vagabond84
|
41 |
16K |
4 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
41
|
16K
|
4
|
|